RAPT Therapeutics, Inc. (RAPT) Change in Acquisitions & Divestments (2020 - 2024)
RAPT Therapeutics' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $30.0 million for Q4 2024.
- For Q4 2024, Change in Acquisitions & Divestments fell 60.56% year-over-year to $30.0 million; the TTM value through Dec 2024 reached $135.0 million, down 49.38%, while the annual FY2024 figure was $135.0 million, 49.38% down from the prior year.
- Change in Acquisitions & Divestments for Q4 2024 was $30.0 million at RAPT Therapeutics, down from $35.9 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $76.0 million in Q4 2023 and bottomed at $1.4 million in Q4 2021.
- The 5-year median for Change in Acquisitions & Divestments is $32.8 million (2024), against an average of $36.0 million.
- The largest annual shift saw Change in Acquisitions & Divestments plummeted 95.58% in 2021 before it skyrocketed 2483.41% in 2022.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $32.3 million in 2020, then tumbled by 95.58% to $1.4 million in 2021, then surged by 2483.41% to $36.9 million in 2022, then skyrocketed by 105.77% to $76.0 million in 2023, then crashed by 60.56% to $30.0 million in 2024.
- Per Business Quant, the three most recent readings for RAPT's Change in Acquisitions & Divestments are $30.0 million (Q4 2024), $35.9 million (Q3 2024), and $36.4 million (Q2 2024).